V

vTv Therapeutics

D
VTVT
USD
-0.97
(-6.7737%)
Market Closed
416.00
Volume
-0.21
EPS
-
Div Yield
-1.954612
P/E
32,478,640.95
Market Cap
Today
-6.7737%
1 Week
-2.909%
1 Month
-6.643%
6 Months
-45.175%
12 Months
-12.882%
Year To Date
16.594%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
V
VBIV
(%)
USD
A
ACST
(%)
USD
B
BHVN
-0.645
(-1.2013%)
USD
C
CRBP
-0.36
(-1.9027%)
USD
E
EOLS
-2.495
(-14.8733%)
USD
F
FLXN
(%)
USD
M
MRTX
(%)
USD
O
OMER
-0.04
(-0.8801%)
USD
S
SAGE
0.385
(6.4815%)
USD
S
SRPT
-7.62
(-5.9531%)
USD

Title:
vTv Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
Do you need help or have a question?
Contact Us